Zymeworks Inc. (ZYME) Financials

ZYME Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 580.9 million 116.1 million
2023-09-30 556.4 million 132.0 million
2023-06-30 602.1 million 153.1 million
2023-03-31 600.7 million 127.2 million

ZYME Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 12.2 million 3.4 million
2023-09-30 -43.8 million 2.0 million
2023-06-30 -7.2 million 367000
2023-03-31 -83.6 million 2.3 million

ZYME Net Income

No data available :(

ZYME Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 374.3 million - 26.7 million
2023-09-30 295.4 million - 26.4 million
2023-06-30 340.1 million - 27.3 million
2023-03-31 412.4 million - 27.3 million

ZYME Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 70.1 million
2023-09-30 70.6 million
2023-06-30 67.3 million
2023-03-31 66.7 million

ZYME Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 1.8 million 25.5 million 14.8 million -
2023-09-30 1.1 million 16.5 million 17.0 million -
2023-06-30 802000 39.4 million 21.7 million -
2023-03-31 386000 45.9 million 16.9 million -

ZYME Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 16.9 million -
2023-09-30 16.5 million 32.9 million
2023-06-30 7.0 million 39.4 million
2023-03-31 35.6 million 45.4 million

ZYME

Price: $9.20

52 week price:
6.02
13.14

Earnings Per Share: -1.72 USD

P/E Ratio: 3.45

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 105946

Ebitda: -15.5 million

Market Capitalization: 652.8 million

Links: